Blessing JA - Search Results

1

A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.

Sutton GP, Blessing JA, DeMars LR, Moore D, Burke TW, Grendys EC. Sutton GP, et al. Among authors: blessing ja. Gynecol Oncol. 1996 Oct;63(1):25-7. doi: 10.1006/gyno.1996.0272. Gynecol Oncol. 1996. PMID: 8898163 Clinical Trial.

2

Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.

Sutton G, Blessing J, Hanjani P, Kramer P; Gynecologic Oncology Group. Sutton G, et al. Gynecol Oncol. 2005 Mar;96(3):749-52. doi: 10.1016/j.ygyno.2004.11.036. Gynecol Oncol. 2005. PMID: 15721421 Clinical Trial.

3

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study.

Rose PG, Blessing JA, Ball HG, Hoffman J, Warshal D, DeGeest K, Moore DH. Rose PG, et al. Among authors: blessing ja. Gynecol Oncol. 2003 Feb;88(2):130-5. doi: 10.1016/s0090-8258(02)00091-4. Gynecol Oncol. 2003. PMID: 12586591 Clinical Trial.

4

A phase II evaluation of flavopiridol as second-line chemotherapy of endometrial carcinoma: a Gynecologic Oncology Group study.

Grendys EC Jr, Blessing JA, Burger R, Hoffman J. Grendys EC Jr, et al. Among authors: blessing ja. Gynecol Oncol. 2005 Aug;98(2):249-53. doi: 10.1016/j.ygyno.2005.05.017. Gynecol Oncol. 2005. PMID: 15978659 Clinical Trial.

5

Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.

Garcia AA, Blessing JA, Darcy KM, Lenz HJ, Zhang W, Hannigan E, Moore DH. Garcia AA, et al. Among authors: blessing ja. Gynecol Oncol. 2007 Mar;104(3):572-9. doi: 10.1016/j.ygyno.2006.09.002. Epub 2006 Oct 17. Gynecol Oncol. 2007. PMID: 17049588 Free PMC article. Clinical Trial.

6

Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group study.

Sutton GP, Blessing JA, Adelson MD, Hanjani P. Sutton GP, et al. Among authors: blessing ja. Invest New Drugs. 1990 Nov;8(4):377-9. doi: 10.1007/BF00198594. Invest New Drugs. 1990. PMID: 2084071 Clinical Trial.

7

Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.

Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD. Sutton GP, et al. Among authors: blessing ja. Cancer Chemother Pharmacol. 1990;26 Suppl:S55-8. doi: 10.1007/BF00685421. Cancer Chemother Pharmacol. 1990. PMID: 2112054

8

Gynecologic Oncology Group experience with ifosfamide.

Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD. Sutton GP, et al. Among authors: blessing ja. Semin Oncol. 1990 Apr;17(2 Suppl 4):6-10. Semin Oncol. 1990. PMID: 2159188 Clinical Trial.

9

Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.

Sutton GP, Blessing JA, Barnes W, Ball H. Sutton GP, et al. Among authors: blessing ja. Am J Clin Oncol. 1990 Dec;13(6):470-1. doi: 10.1097/00000421-199012000-00003. Am J Clin Oncol. 1990. PMID: 2239800 Clinical Trial.

10

Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.

Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Williams SD, et al. Among authors: blessing ja. Ann Intern Med. 1989 Jul 1;111(1):22-7. doi: 10.7326/0003-4819-111-1-22. Ann Intern Med. 1989. PMID: 2472080 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page